The Microdose AI and The Deep View both gave readers serious AI business news on June 25, 2026. The Deep View led with OpenAI’s Jalapeño chip and the company’s push down the AI stack. The Microdose AI led with Gartner’s warning that AI coding tools could cost more than developers, then widened the issue into cybersecurity, geopolitics, quantum claims, and medical AI.
On June 25, 2026, The Microdose AI was the stronger AI newsletter for tech professionals who needed a sharper read on AI costs, risk, and incentives. The Deep View had the fuller OpenAI chip analysis and a useful KPMG section on worker adoption of agents. But The Microdose AI made the better daily editorial call by treating tokens, AI coding bills, Chinese bug hunters, AI Cold War risk, Microsoft quantum claims, and medical AI loopholes as connected business and trust problems.
Best AI Newsletter 2026
At a glance
- Verdict: The Microdose AI had the stronger issue for readers tracking AI economics, enterprise risk, and frontier tech consequences.
- Comparison: The Microdose AI made AI cost and credibility the central fight, while The Deep View focused on OpenAI’s infrastructure ambitions and agent adoption.
- The Microdose AI’s best call: Leading with Gartner’s AI coding cost warning turned token pricing into a boardroom issue.
- The Deep View’s best call: Its Jalapeño analysis connected OpenAI’s chip move to compute control and AI industry centralization.
- Reader takeaway: The Deep View gave readers more depth on OpenAI’s stack. The Microdose AI gave readers the sharper map of where AI hype gets expensive, political, and hard to verify.
The Microdose AI vs The Deep View
How two AI newsletters framed the cost of intelligence
The Microdose AI opened with politics, not product news. Its cold open covered AI labs pouring money into the midterms to shape rules around AI, data centers, copyright, labor, and safety. Groups linked to OpenAI and Anthropic had already spent a combined $37 million on campaigns, and the issue framed the bipartisan spending as insurance. That set up the day’s deeper theme. AI companies are becoming powerful enough to shape the rules while selling tools that buyers still struggle to price, verify, and govern.
The lead story made that theme concrete. Gartner warned that AI coding companies are moving from flat monthly pricing to token based billing, where every retry, loop, and context pull makes the bill grow. The issue said monthly AI coding costs are climbing from hundreds to thousands, sometimes tens of thousands, per developer. Gartner predicted AI coding costs could surpass the average developer salary by 2028 if companies keep treating tokens like free candy.
The Deep View built its issue around OpenAI and infrastructure. Its lead story covered Jalapeño, OpenAI’s first custom AI inference chip built with Broadcom in nine months. The story explained the chip’s role in OpenAI’s full stack strategy, its promise of better performance per watt, and the company’s move into compute, networking, and long term capacity access. The Deep View then moved into KPMG data on AI agent adoption and Figma’s team based AI product push.
The editorial clash was clean. The Deep View asked whether OpenAI can make compute more abundant and affordable while owning more of the AI stack. The Microdose AI asked who profits when the stack gets expensive, unverified, geopolitical, and sold as progress. One issue gave readers a fuller infrastructure story. The other gave them a stronger smell test.
The Microdose AI vs The Deep View
The Microdose AI vs The Deep View comparison for AI professionals
| Category | The Microdose AI | The Deep View |
|---|---|---|
| Best for | Executives, builders, investors, and security leaders tracking AI incentives and risk | AI readers who want fuller reporting on OpenAI, agents, and product strategy |
| Lead choice | Gartner’s AI coding cost warning made token pricing feel urgent | OpenAI’s Jalapeño chip gave the issue a strong infrastructure anchor |
| Strongest editorial call | Pairing AI coding costs with China’s Mythos rival exposed the price and security sides of agentic AI | Connecting Jalapeño to Guaranteed Capacity and GPU networking showed OpenAI’s stack expansion |
| What it made clearer | AI buyers need to watch costs, verification, regulation, and vendor incentives together | OpenAI wants control across models, products, chips, networking, and compute access |
| What could have been stronger | The Jalapeño fun stat deserved a little more connection to the Gartner lead | The worker adoption story could have questioned the KPMG numbers harder |
| Visual experience | Yellow accents, pixel smileys, and custom art gave the issue strong brand recall | Large card sections, author modules, games, and polls created a magazine style reading flow |
| Advertiser fit | Strong context for AI cost control, security, grounding, compliance, developer tools, and frontier tech sponsors | Strong context for CRM, AI coding, enterprise AI, developer tooling, and broad AI platform sponsors |
Best AI newsletter for executives
Gartner beat Jalapeño as the sharper daily lead
The Deep View made a strong lead choice. OpenAI’s Jalapeño chip is a major story. A first generation intelligence processor built with Broadcom, designed around LLM inference, compatible with all LLMs, and already running workloads tied to GPT-5.3-Codex-Spark gives readers plenty to understand. The Deep View explained the chip through compute abundance, inference efficiency, Nvidia dependence, and OpenAI’s full stack strategy. That was useful.
The Microdose AI still made the better daily lead choice because Gartner’s AI coding cost warning hit closer to actual buyer pain. OpenAI’s chip affects the industry’s infrastructure future. Gartner’s warning affects the next invoice. That is the kind of distinction busy executives care about, even if they pretend otherwise on LinkedIn.
The Microdose AI turned token pricing into a simple executive question. If every agentic coding workflow thinks, retries, loops, and grabs more context, who controls the meter? The issue made clear that many companies still assume more tokens mean more productivity, while Gartner sees no direct evidence that the two move together. That is a useful warning because AI coding tools are no longer judged only by demos. They are judged by burn rate.
The best sentence in the lead was the one about vendors celebrating tokenmaxxing because they sell the tokens. It made the incentive structure obvious. A developer may want better output. A company may want faster shipping. A vendor may want heavier usage. Those goals can overlap, but they can also diverge fast once the pricing model rewards computational wandering.
The Deep View’s Jalapeño lead had more reporting detail. The Microdose AI’s Gartner lead had stronger decision value. For readers choosing the best AI newsletter 2026 for work, money, or roadmap impact, the developer cost story was the sharper first punch.
The Deep View on OpenAI infrastructure
The Deep View had the stronger OpenAI stack analysis
The Deep View deserves clear credit for its OpenAI section. It did more than summarize a chip announcement. It showed how Jalapeño fits inside a wider OpenAI strategy to own more layers of AI infrastructure. The story connected the chip to model performance, inference efficiency, power consumption, Broadcom, datacenter hardware, and OpenAI’s ambition to deploy 10 gigawatts of custom AI accelerators.
The best part came in its deeper analysis. The Deep View connected Jalapeño to OpenAI’s Guaranteed Capacity product and Multipath Reliable Connection, its open source GPU networking standard. That moved the story beyond chips. OpenAI is not only building models and apps. It is moving into the systems that decide who gets compute, how efficiently models run, and how much of the AI economy depends on its infrastructure decisions.
The centralization angle was also well chosen. The Deep View noted that OpenAI and other major tech firms have raised concerns about power concentrating in AI while OpenAI embeds itself across the stack. That is the right tension. OpenAI says it wants broader access to intelligence. OpenAI also wants to own more of the machinery behind that access. Wonderful. The toll road is democratizing transportation.
The Microdose AI mentioned Jalapeño only in Fun Stats, noting that OpenAI went from zero to its first custom AI inference chip in nine months. That was a good quick hit, but it left a stronger connection on the table. The issue’s lead was about AI coding economics. OpenAI’s chip story was also about inference economics. A small bridge between those two would have made the issue even tighter.
This was The Deep View’s cleanest win. Its OpenAI piece gave readers the fuller stack view and named the infrastructure chess pieces. The Microdose AI had the better issue argument. The Deep View had the better OpenAI chapter.
AI agents and cybersecurity risk
The Microdose AI made agentic AI feel more dangerous and more expensive
The Microdose AI’s second major story was China’s claim that it has its own Mythos rival. Chinese cybersecurity giant 360 Security says Tulongfeng found 3,432 software flaws, with Chinese authorities confirming 105. The issue also noted that there were no public benchmarks and Reuters could not verify the numbers. That caveat mattered. The story was not written as hype. It was written as a claim with geopolitical and security consequences.
The editorial choice was smart because it put the reader in the right posture. Anthropic’s Mythos showed the security world what happens when AI starts finding vulnerabilities at scale. China claiming a rival system raises a different problem. If agentic AI can hunt bugs faster, the gap between defensive research and offensive discovery gets thinner. The Microdose AI did not drown the story in technical detail. It gave the reader the number, the verification problem, the geopolitical frame, and the nightmare scenario.
The AI Cold War section pushed the same question harder. The issue tied US chip controls, Chinese open models, and faster agentic cyberattacks into one short piece. MIT’s Stephen Casper warning about cooperation before an AI Chernobyl moment gave the story a human voice. The Microdose AI then made the uncomfortable point. Cooperation sounds nice until the countries involved remember they are still trying to beat each other.
The Deep View touched agent adoption through KPMG data. Its workforce story said only 2% of tech leaders report significant worker pushback, while employee adoption of AI agents has reached 68%. It also noted that 63% of organizations require human review of agent outputs and that many deployments remain limited to low risk tasks like IT ticket triage or HR questions. That was useful, especially because The Deep View ended by saying today’s assistant style agents may feel different once they behave more like coworkers, such as Anthropic’s Claude Tag.
The weakness was that The Deep View did not press the adoption data hard enough. If companies are deploying AI without full visibility into costs, with average AI investments projected at $269 million over the next 12 months, then worker adoption is only part of the story. The harder question is whether companies know what they are buying, what they are measuring, and what risks they are normalizing. The Microdose AI was stronger on that front.
AI newsletter for researchers and tech leaders
Microsoft quantum and medical AI gave The Microdose AI the better verification test
The Microdose AI’s strongest issue pattern was verification. It kept asking whether impressive claims can be trusted. Gartner says more tokens do not automatically mean more productivity. 360 Security claims thousands of flaws, but public benchmarks are missing. Microsoft says Majorana showed up in its chips, but outside scientists still cannot fully verify the breakthrough. AI companies say their health tools are support software, while the tools increasingly help doctors think through clinical cases.
The Microsoft quantum story was especially useful. The issue explained that Microsoft has chased Majorana for more than 20 years because the particle could make quantum computers easier to scale. Then it gave readers the credibility problem. UK physicist Henry Legg says Microsoft’s verification tool has coding errors and is not accurate enough to support the claim. Microsoft stands by its work and says it shared data with DARPA. Outside scientists still cannot fully verify it.
That is the right level of detail for a daily brief. The reader does not need a lecture on quantum mechanics. The reader needs to know that a major company is making a high stakes claim, a credible physicist is challenging the validation method, and public verification has not caught up to the marketing. The Microdose AI landed the point without turning the issue into a seminar nobody asked to attend.
The medical AI story carried the same logic into regulation. AI companies call tools support software, wellness apps, or patient education, which helps keep them outside the FDA’s medical device lane. The issue then added the pressure. An AMA survey said 80% of doctors already use AI at work, and a Harvard and Stanford study found ChatGPT outdiagnosed hundreds of physicians on real patient cases. The conclusion was careful. The issue did not say AI is ready to replace doctors. It said the line between support tool and doctor is getting blurry fast.
The Deep View’s Figma story had a different strength. It gave readers a thoughtful product read on AI as a team layer, with Code Layers, Motion and Shader tools, Weave workflows, and agent skills. The strongest editorial choice was quoting Dylan Field saying Figma does not expect creative breakthroughs that differentiate companies to come from AI any time soon. That was a good counterweight to automation cheerleading. But as a full issue, The Microdose AI had the better verification discipline.
AI newsletter visual identity and reader trust
The Deep View used stronger modules while The Microdose AI felt more authored
The visual comparison was a real tradeoff. The Deep View used a polished magazine style structure with a large hero image, rounded story cards, category labels like Hardware, Workforce, and Products, author modules under deeper analysis, sponsor blocks, link sections, AI tools, jobs, games, and poll results. The issue had a lot of furniture, but the room labels were clear.
The Jalapeño lead especially benefited from that structure. A major chip story with a large visual, bullets on architecture and performance, expert commentary, and a named deeper analysis section gave the piece weight. The Deep View also used reader interaction well. The AI or Not game and poll on AI centralization made the issue feel participatory without hijacking the news.
The Microdose AI had a tighter visual identity. The black logo, yellow accent, pixel smiley divider, and custom blue and orange coding image created immediate brand memory. The issue looked less like a content platform and more like a sharply edited note from people who know what they are trying to say. That is a strength when the product promise is clarity at speed.
The sponsor context also worked for both issues. You.com’s grounding guide fit The Microdose AI’s verification heavy issue, especially with stories about token costs, Chinese security claims, Microsoft quantum evidence, and medical AI boundaries. Lightfield fit The Deep View’s agent adoption and workplace sections, while JetBrains fit the AI coding agent theme. The Deep View had more sponsor real estate. The Microdose AI had cleaner editorial sponsor alignment.
The Deep View won on modular packaging. The Microdose AI won on issue identity. Broad polish gets attention. A memorable voice gets remembered. There is a difference, and newsletters that forget it usually end up sounding like SaaS onboarding screens with weather.
Best AI newsletter for builders and investors
The Microdose AI served readers making AI spending decisions
The Microdose AI was better for readers who need to make decisions around AI spending, vendor claims, security risk, and frontier tech credibility. Its issue had a clear job. Help the reader understand where AI hype becomes a bill, a campaign donation, a cyber weapon, a weak quantum claim, or an unregulated medical assistant.
That is why the Gartner lead mattered so much. AI coding tools are being sold as productivity boosters. The Microdose AI asked whether the pricing model rewards productivity or consumption. That is a better question than whether the demo looks cool. Most demos look cool. Some invoices look like a raccoon got into the procurement system.
The Deep View served readers who wanted more detail on major AI company moves. Its OpenAI story was the most complete single analysis in either issue, and the Figma story gave a thoughtful view of collaborative AI product design. Its KPMG section helped readers see that agent adoption is already happening faster than public anxiety might suggest. Those are valuable pieces.
But The Deep View spread its attention across OpenAI infrastructure, worker adoption, Figma, tools, jobs, games, and polls. The Microdose AI delivered a more concentrated editorial argument. The issue kept returning to the same question from different angles. Can the people buying, regulating, deploying, and trusting AI actually verify what they are being sold?
For a founder, CISO, CTO, investor, or AI lead, that was the higher value read. The Microdose AI gave readers a way to think, not only a list of things that happened.
Advertiser fit for The Microdose AI vs The Deep View
Which AI newsletter created the better sponsor context on June 25
The Microdose AI created strong context for sponsors selling into AI cost control, developer productivity, cybersecurity, model grounding, compliance, healthcare AI, data governance, quantum scrutiny, and frontier tech. The You.com sponsorship fit because the issue repeatedly returned to evidence, grounding, verification, and hallucination risk. A grounding guide belongs in an issue asking readers to stop believing every impressive AI claim on first contact.
The issue also created strong context for security and infrastructure sponsors. The China Mythos rival, AI Cold War cyber risk, Microsoft verification challenge, and AI medical loophole all served readers who care about risk controls. Sponsors in AI security, audit trails, cloud governance, model evaluation, identity, and compliance would find a natural editorial environment here.
The Deep View created a strong sponsor environment for enterprise AI platforms and developer tools. Lightfield’s agentic CRM fit the workforce adoption story, while JetBrains’ Junie ad matched the coding agent discussion. The Deep View also has many sponsor surfaces, including top placement, mid issue cards, tools, jobs, podcast promotion, and a direct advertiser note tied to its 750,000 plus audience claim.
The advertiser choice depends on intent. The Deep View offered scale, a broad AI reader base, and polished modular placement. The Microdose AI offered a tighter editorial room for sponsors that want readers thinking about AI cost, trust, security, and business consequence. For that kind of sponsor, advertise with The Microdose AI is the cleaner context.
Final verdict on The Microdose AI vs The Deep View
The Microdose AI had the sharper AI business read on Jun 25
The Deep View won the OpenAI infrastructure story with a strong Jalapeño breakdown and useful context on OpenAI’s full stack ambitions. The Microdose AI won the issue because Gartner’s token cost warning, China’s Tulongfeng claim, AI Cold War risk, Microsoft’s quantum credibility problem, and medical AI loopholes gave readers a tougher, more useful read on AI economics and trust. For busy tech professionals choosing the better AI newsletter on June 25, The Microdose AI made the stronger editorial calls.
The Microdose AI vs The Deep View FAQ
Frequently asked questions about The Microdose AI vs The Deep View
Which newsletter was better on June 25, 2026?
The Microdose AI was better for readers tracking AI costs, risk, and business consequence. The Deep View had the stronger OpenAI chip analysis, but The Microdose AI built the stronger full issue around AI economics, verification, security, and regulation.
Which AI newsletter handled OpenAI’s Jalapeño chip better?
The Deep View handled Jalapeño better. It explained the Broadcom partnership, inference focus, performance per watt claims, OpenAI’s full stack strategy, and the broader centralization concern around OpenAI owning more layers of AI infrastructure.
Which AI newsletter was better for developers and CTOs?
The Microdose AI was better for developers and CTOs focused on AI coding economics. Its Gartner lead explained why token based pricing could make coding agents expensive fast, especially when agents retry, loop, and pull more context.
Where did The Deep View beat The Microdose AI today?
The Deep View beat The Microdose AI on OpenAI infrastructure depth and modular product coverage. Its Figma section also gave readers a thoughtful look at AI as a team based design and development layer.
Which newsletter was better for advertisers?
The Deep View offered broad AI scale and polished sponsor modules. The Microdose AI offered stronger context for sponsors tied to AI cost control, security, grounding, compliance, developer tooling, and frontier tech decisions.